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Simple Summary: The sterile insect technique is familiar to agricultural pest management and is 
now being increasingly applied to mosquitoes as part of integrated vector management programs. 
This review leans on a growing literature and on the experience of its many authors to describe the 
key steps, and the challenges to be surmounted, in order to design and execute successful pilot 
studies in many environments. We emphasize integrating stakeholder mapping and engagement at 
all levels. Included are introductory descriptions of the key elements to (1) ensure wide stakeholder 
support through transparent communication plans and the identification of regulatory and finan-
cial frameworks; (2) select suitable field sites; (3) build a sound, and locally-adapted, integrated 
vector management strategy; (4) access the technical advancements to ensure high-quality releases; 
and (5) reliably assess the impacts and benefits of the field trial. 
Abstract: Aedes albopictus and Aedes aegypti are invasive mosquito species that impose a substantial 
risk to human health. To control the abundance and spread of these arboviral pathogen vectors, the 
sterile insect technique (SIT) is emerging as a powerful complement to most commonly-used ap-
proaches, in part, because this technique is ecologically benign, specific, and non-persistent in the 
environment if releases are stopped. Because SIT and other similar vector control strategies are be-
coming of increasing interest to many countries, we offer here a pragmatic and accessible ‘roadmap’ 
for the pre-pilot and pilot phases to guide any interested party. This will support stakeholders, non-
specialist scientists, implementers, and decision-makers. Applying these concepts will ensure, given 
adequate resources, a sound basis for local field trialing and for developing experience with the 
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technique in readiness for potential operational deployment. This synthesis is based on the available 
literature, in addition to the experience and current knowledge of the expert contributing authors 
in this field. We describe a typical path to successful pilot testing, with the four concurrent devel-
opment streams of Laboratory, Field, Stakeholder Relations, and the Business and Compliance Case. 
We provide a graphic framework with criteria that must be met in order to proceed.  




Aedes aegypti and Aedes albopictus are invasive mosquito vector species that impose a 
substantial risk to human health. To control the abundance and spread of these arboviral 
pathogen vectors, sterile insect technique (SIT)-based approaches are a powerful comple-
ment to currently available methods. This technique is environmentally benign, 
specifically targeted, spatially constrained, and non-persistent, features which can help 
protect public health, non-target fauna, and the environment. Originally conceived for 
eradication of agricultural pest species, it was first proposed for vector species over 50 
years ago [1] and using mosquito SIT as part of an integrated vector management (IVM) 
approach is now a reality for vector-borne disease control stakeholders. 
The sterile insect technique disrupts the target organism’s reproductive cycle. Mass-
reared males, sterilized using X-ray or gamma-ray ionisation, are released and may then 
mate with wild females, resulting in inseminations that do not produce progeny. Since the 
1930s [2,3], SIT has been progressively applied in agriculture, contributing to the 
management of at least 20 species of insect pests [4,5]. The first effective applications of 
SIT to mosquitoes were in the 1960s and 1970s with pilot trials against Culex quinquefasci-
atus [6] and the malaria vectors Anopheles quadrimaculatus in Florida, USA [7], and An. 
albimanus in El Salvador, Central America [8]. Development and improvement of the 
technical steps have led to international interest in using SIT against some major vector 
species of Plasmodium spp. (malaria) (Anopheles arabiensis) and dengue virus (Ae. albopictus 
and Ae. aegypti). Pilot trials have now been performed on several continents [9], though 
few have yet been fully reported in peer-reviewed literature [10]. A recent field trial using 
a combination of SIT and the insect incompatibility technique (IIT, using the bacterium 
Wolbachia) succesfully reduced populations of Ae. albopictus in the residential areas of two 
small islands in Guangzhou, China [11]. In contrast to the long-established use of SIT in 
agriculture, application against human disease vectors requires more attention to the so-
cial perspective [12], mainly because pilot trials in urban areas need communication with 
multiple stakeholders and residents. Moreover, their direct interest in contributing to the 
vector control effort may appear less obvious to residents than to growers for whom yield 
and income depend on pest management success. Many lessons have been learnt [9], alt-
hough further small-scale tests in a range of representative field situations are needed to 
demonstrate the wider operational efficiency of SIT for reducing mosquito populations 
below nuisance levels. Larger and longer-term pre-commercial programs will then assess 
cost effectiveness and impact on pathogen transmission thresholds. We describe here the 
crucial steps in planning and performing an SIT pilot test, while also setting the stage for 
future large-scale implementation. 
Programs or stakeholders considering SIT as a contributor to their mosquito control 
activities will need local field pilot trials to demonstrate, evaluate, and calibrate effort in 
their specific context. Pilot trials can evaluate effectiveness and provide a first estimation 
of cost efficiency but also develop capacity for local SIT product delivery, for example, 
training of staff in new techniques and competencies, and engagement with public 
perception. Pilot trials can identify logistical, technological, and financial constraints to 
designing successful, longer-term wider-area IVM strategies. The explosive growth in 
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scientific articles on specific steps in the SIT development process against mosquitoes is 
guided largely by specific research questions (reviewed by Lees et al. [13]), but a practical 
overview of pilot trial design and implementation is needed. Here we provide an 
accessible, harmonized, and structured ‘guide to process’ with subsets of conditions, 
based on key criteria, which must be met to support a journey towards well-conducted 
SIT trials (Figure 1). As part of the the European Union’s Zikaliance project [14] subtask 
on innovative vector control solutions, we hope specifically here to assist novice 
practitioners overcome potential problems, avoid wasted time, and increase their chances 
for successful control of Aedes spp. and Aedes-borne diseases. 
 
Figure 1. A decision tree for progression towards the implementation of a sterile insect technique (SIT) pilot field trial for 
vector mosquito management. 
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The operational implementation of SIT is a phased conditional pathway (outlined in 
[15]): (i) determining feasibility, (ii) pilot testing, and (iii) operational/commercial 
program. This review describes the underpinning steps of the demonstration stages and 
the sequence of concurrent activities needed to determine feasibility (Figure 2), which 
largely focusses on developing technical capacities, funding model and stakeholder 
relationships, to the pilot trial. It does not cover operational phases or provide the 
advanced technical guidance covered by the International Atomic Energy Agency (IAEA) 
protocols [16] and the Joint IAEA and World Health Organisation (WHO) guidelines [17]. 
We provide, for a broad range of interested parties, an experienced, consensus viewpoint 
of ‘how to start’ with key go/no-go criteria. The features of SIT development critical to 
success are: stakeholder engagement at all levels; suitable pilot study sites; knowledge of 
target species dynamics and distribution under local field conditions; biological and 
technical requirements (including sex separation) for mass-rearing and sterile male 
releases, in addition to the design and evaluation criteria for small-scale field testing of 
sterile mosquito releases within IVM (Figure 1). This paper thus provides an accessible 
and compact document that is a pragmatic synthesis of the steps towards SIT pilot 
demonstration and is a support to early decision-making for the prevention of mosquito-
borne diseases and nuisance control. 
2. Opening Steps—Determining Feasibility 
Several work streams will develop alongside one another as the project progresses 
(Figure 2), but it is important to first look carefully at the feasibility at the planned location. 
 
Figure 2. Illustrative timeline of the steps towards the implementation of a sterile insect technique (SIT) pilot field trial for 
vector mosquito management. 
2.1. Stakeholder Mapping, Regulatory Framework and Approval 
An important early step is to ‘map the stakeholders’, that is, to understand who 
should be included in the project’s dialogue and development, and consider how and 
when they can be engaged (Figure 2). The first step in this, however, is to obtain outline 
approval or consensus at the highest level of the relevant authorities.  
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Ministry-level stakeholders are likely to be aware of SIT, but policy-makers at local 
(regional or prefectoral) levels may appreciate background information. Communicating 
the historical context and national regulatory status (if any, or the regulatory approaches 
in other countries) along with outline information about the specific SIT pilot trial and the 
potential major application of its outcomes is important. The interest and acceptance of 
these decision-makers and establishing the potential for funding are pre-requisites for the 
development of a sustainable program. These conversations should use language 
appropriate to the recipient; it must be accessible, informative, and not overly-detailed 
and cautious (i.e., not overstate or propose a specific effect size for a trial). In 
circumstances where a potential trial area is identified early, having prior municipal-level 
support will help with approaching funders and policy-level actors. This is also a 
prerequisite for undertaking costly and complex actions, such as detailed entomological 
surveys or extensive stakeholder engagement at a site (Figure 1). 
The regulatory context for SIT varies between countries and a clear framework is not 
common. There are no specific international regulations governing the use of radio-
sterilized insects for pest control, although the International Standard for Phytosanitary 
Measures (ISPM) No. 3 [18] provides useful support and indicates requirements and 
standards for exporting, shipping, and releasing biological control agents and other 
beneficial organisms, such as sterile insects in agriculture. The recent common guidance 
by WHO-IAEA for SIT as a vector control solution [17] can further help public acceptance 
[19,20] and official support. From the outset it is important to determine which local and 
national authorities and regulations govern the release of sterile mosquitoes, because lack 
of clarity can lead to delay. In Brazil there were delays of two years [21] and in Reunion 
Island of five years before authorization to release was given [22]. In Europe, SIT programs 
using radio-sterilized male mosquitoes have been performed in the absence of a specific 
official regulatory framework but after validation by local authorities in Germany, Greece, 
Italy, Montenegro, and Spain [23].  
Although SIT is generally accepted in the agricultural sector, human-health related 
interventions often require a consensus that matches social perceptions with scientific ev-
idence. Establishing an advisory forum with locally relevant stakeholders is a useful 
relationship management strategy and provides a route to voice opinions. The 
stakeholder groups represented may include other pest control practitioners, expert 
scientists (entomologists, ecologists, epidemiologists, sociologists, mathematicians), 
religious groups, environmental associations, local politicians, local health professionals 
and services, and other interested parties such as school teachers or community groups. 
Encouraging two-way interactions with these groups ensures a legitimate approach. All 
key local players must have accurate information and understanding so that public 
dissemination through these trusted channels is correct and useful.  
2.2. Messaging Content and Progression 
The engagement content follows a typical progression. Creating a profile for the 
problem and challenge faced (disease risk, nuisance, or both) helps when it comes to 
proposing unfamiliar technological solutions. The information should start with the 
biology and ecology of these urban mosquitoes and then describe the limitations of 
current traditional vector control methods. It is only later when uncertainties about the 
project are dispelled (plans, sites, and political support confirmed) that introducing the 
concept of SIT becomes useful [12,13].  
At all stakeholder levels, transparent and participative decision-making processes 
are important for the success of integrated vector management (IVM) strategies. Local 
engagement is crucial for supporting IVM (e.g., by raising awareness of breeding sites and 
their reduction) and thus improves later likelihood of success of SIT. Useful information 
is available from the World Mosquito Program (formerly Eliminate Dengue) in Australia 
[24], where the engagement framework was designed to integrate the community with 
the program and increase their familiarity with the technical and research components. 
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Early perception surveys among residents in La Reunion demonstrated that providing 
information several times worked to increase the social acceptance of SIT there (see [22]).  
Understanding Stakeholder Concerns 
Suppressing vector populations through a biocontrol approach that reduces the use 
of chemicals will have positive impacts on health and the environment [25], although this 
can raise questions about potential unintended effects and teams should be prepared for 
this. The main concerns generally expressed are: (i) the risks associated with accidental 
releases of sterile females; (ii) the risks of released males not being fully sterile; (iii) the 
effects of releases of large numbers of individuals on associated fauna (predators and com-
petitors for food resources); (iv) changes in species’ abundance and interactions via 
reduced larval competition; (v) the potential for population replacement by an alternative 
vector species in the vacant niche; and (vi) the potential for ionizing radiation contamina-
tion by released males.  
Where Ae. aegypti or Ae. albopictus are recent invasive species, it is unlikely that their 
suppression would negatively affect local biodiversity. Where these species are endemic 
or naturalized, the demonstrated wide use of SIT in agriculture helps provide reassurance 
[25]. The Organization for Economic Co-operation and Development (OECD) consensus 
document on the biology of Ae. aegypti [26] describes the ecological role of Aedes mosqui-
toes in the environment and also discusses biosafety issues arising from certain vector 
control practices. Environmental guidance documents, based on ecological evaluations of 
Aedes suppression such as those developed for Anopheles gambiae [27], are needed, alt-
hough the biology of these species is well described [26]. While there will be local 
considerations, these would provide a comprehensive framework and inform planning of 
specific local ecological studies. Transparency throughout the process helps gain the 
stakeholder support needed for open-field trials [28], and the IAEA supports this with 
answers to many common questions [29]. 
2.3. Ethical Approvals 
Pilot testing a new vector control strategy in urban and peri-urban areas often needs 
specific ethical approval for the pilot study [30]. This can be given by an institutional ethics 
board or other appropriate committee and, if applicable, by any relevant national or 
regional board. The community engagement plan can be used to demonstrate 
accountability to ethics boards by having appropriate and relevant communication, and 
associated risk assessment, based on an inventory of identified plausible risks [28,31]. 
There are particular ethical considerations for trials taking place in regions where 
education and literacy may be limited and communication plans are vital [32].  
2.4. Financial Planning 
To justify a pilot trial, decision makers and potential funders are likely to need an 
estimate of the long-term costs and benefits expected from a successful operational SIT 
implementation. There are numerous pest cost–benefit examples to support this [33]. 
Initial predictions can use econometric studies which report past and current costs of 
vector control measures [34,35], the spend on protection against mosquito bites by 
households [36], the impact on the tourism industry [37], and labour or social costs of 
disease cases for the country or region, such as disability-adjusted life years (DALYs) [38]. 
For example, in La Réunion, household-level expenditure on protective measures in 2012 
was estimated at circa USD 28 million [36] and in Malaysia in 2009, the cost of dengue was 
estimated at USD 102 million (direct medical costs and costs related to lost productivity 
and premature mortality) [39]. Within the past decade, the global economic costs of 
invasive Aedes and their associated diseases are variously estimated to be at least USD 9–
60 billion per year, though these are considered to be seriously underestimated [40–42]. 
Pilot trials will always be less cost-effective than large-scale implementation, where 
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economies of scale will help reduce the unit production costs and female immigration 
from non-treated areas is reduced. 
Estimating the costs of a pilot trial is difficult before the workplan and resources 
required are drawn up, and will depend partially on locally available skills and 
infrastructure, and already existing entomology surveillance. Estimating expenditure, 
even loosely, does allow useful comparisons with other control strategies and a wide 
variety of elements should be considered (Table 1 shows indicative components). A 
spreadsheet for the design of a mass-rearing facility to produce sterile male Aedes is 
available [43] to estimate the insect production component and can be used to compare 
with the costs of purchase from an established source. Mathematical models developed to 
estimate the costs of novel mosquito control technologies [44] can also be applied to SIT. 
The experience gained in costing and administering a trial will help improve long-term 
planning processes. Author experience suggests that in Europe where there is available 
expertise and practical support, preparation and trial can be achieved within four to five 
years for as little as EUR 200,000. 
Table 1. Pilot trial sample cost items. 
Stakeholder engagement Production 
Message development Larval and adult diet 
Media costs (electronic and printing) 
Social networking 
Staff training and costs 
Sex sorting 
Staff training + costs Disposable materials 
Transport and site costs Sterilization (local or through purchase) 
Facility operation Release and monitoring 
Facility leasing, renovation or purchase costs Staff training and costs 
Administration Traps 
Maintenance and utilities Disposable materials 
Cleaning services and staff costs Transport and site costs 
Waste disposal Data management and analysis 
2.5. Aligning with Current Vector Management 
The sterile insect technique is rarely a stand-alone tool and designing integrated 
vector management (IVM) approaches which combine sterile male releases with 
commonly used mosquito control interventions of proven efficacy is essential [45], both 
for pilot testing and for large-scale implementation (Figure 1). This creates the potential 
to reduce the target vector population in ways difficult to achieve with any single method 
and provides the basis for cost-effective and optimal use of available resources. 
Understanding and integrating with, or extending, the currently used tools in the area of 
interest is important as a springboard. 
Combining Tools and Techniques for Integrated Vector Management 
Traditional vector control methods (e.g., insecticide sprays and larval habitat 
reduction) are likely to be in use and locally familiar. In a pilot SIT trial they can be 
enhanced to reduce the local mosquito population, thus creating improved conditions for 
SIT, which is more effective at lower population densities. At the pilot scale, the release of 
sterile male mosquitoes is not a substitute for these common vector control activities. 
Maintaining these is important in the comparison between reference and treatment sites, 
and they are also the only ethically appropriate option if other vector interventions are 
already in place [46].  
The individual effects of existing tools on vector density reduction are poorly 
understood and hard to measure [47]; reviewed in [48]. In addition, none of the ongoing 
and already reported small-scale field trials (e.g., Italy [49], China [11]) have an 
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experimentally subset use of IVM components. Consequently, the specific combination of 
existing tools within any IVM package should initially be discussed with the current local 
vector control services. 
Coordinating with local vector control agencies and, where appropriate, research 
institutions, in addition to communities, is important to make IVM more efficient, 
sustainable, and cost effective [48]. With some understanding of the local efficacy of 
specific methods, modelling can support planning of an IVM strategy and contribute to 
overall efficiency by optimizing the combination of control methods. Table 2 outlines 
some methods that may complement the deployment of sterile male releases, emphasiz-
ing an IVM approach with low insecticide use, but focusing on source reduction and mass 
trapping. 
Table 2. Mosquito control methods compatible with sterile insect technique (SIT) of mosquitoes as 
part of an integrated vector management (IVM) approach. 
Source reduction ranges from simply reducing artificial larval sites (removing or 
draining non-essential or disposable containers on most properties), to long-term 
habitat-altering measures, and may almost eliminate any need for larviciding. This 
approach, which primarily targets artificial containers in private and public spaces, is 
emphasized in any SIT pilot intervention. This requires the active involvement of the 
community and a public information campaign is essential to obtain community 
mobilization [50,51]. Larval habitat elimination through public engagement is useful, 
but rarely sufficient without the active involvment of supervision from official control 
services [52,53]. 
Door-to-door (DtoD) or house-to-house based reduction of larval habitats of Ae. 
albopictus has been used in several trials in Italy, and is both legally enforced and 
inspected as part of mosquito control in Singapore. This entails regular inspection of 
private properties, with larvicide treatment of permanent larval sites and the removal 
or treatment of temporary ones (source reduction), together with relevant control 
information provided to the residents. In this program, accessing 95% of the private 
properties, resulted in a 69%–72% reduction in the density of Ae. albopictus females and 
a 36%–62% reduction in ovitrap collections [54]. For effective and sustained source 
reduction, DtoD requires appropriate communication materials, planning and 
manpower. 
Larviciding is the use of chemicals or biological agents to control immature stages 
developing in aquatic habitats. The feasibility, effectiveness, acceptability and cost of 
biological larviciding in some countries are summarized in Guzzetta et al. [55]. The most 
widely used tools are biological control agents such as copepods, Bacillus thuringiensis 
israelensis (Bti), Lysinibacillus sphaericus (Ls) and spinosad [56,57], or insect growth 
regulators (IGR) such as diflubenzuron, methoprene and pyriproxifen. Auto-
dissemination (AD) of the pyriproxifen can deliver impressive levels of suppression in 
field trials [58,59]. However, AD works well at high, but not low, mosquito densities 
and some degree of population recovery is expected once pyriproxifen levels fall [60]. 
Area-wide application of pyriproxifen cannot provide long-term reduction in 
mosquitoes because cryptic populations are likely to re-surge; so coupling AD with SIT 
has great potential [60]. Larval habitat treatment with IGRs within release areas may 
also reduce the influence of any immigration by fertile females.  
Physical control by gravid mass-trapping and kill tactics. Each gravid Aedes sp. female 
can lay 100–200 eggs and contribute to rapid population build-up with a generation 
Insects 2021, 12, 191 9 of 26 
 
 
every six to nine days for Ae. albopictus under optimal conditions. Originally developed 
for population monitoring, gravid traps baited with an oviposition medium and with 
either sticky devices or insecticides can reduce local population densities [61,62]. The 
use of three CDC autocidal gravid traps per home in more than 85% of houses within a 
treatment area has shown sustained and effective reductions (80%) of Ae. aegypti 
populations [63–66]. The BG-GAT (Biogents’ Gravid Aedes Trap) against Ae. albopictus 
has shown good results in the USA when house coverage is over 80% [67]. 
Ground or aerial adulticiding with ultra-low volume (ULV) spraying of pyrethroid or 
carbamate insecticides is usually employed during public health emergencies to reduce 
further human disease transmission. Depending on the Aedes species present, indoor or 
outdoor residual treatments can affect vector densities [68]. In some contexts, when the 
natural population of Aedes remains high all year long and where there is no evidence 
of insecticide resistance [69], adulticiding may be neccessary to reduce the wild 
population preceding the sterile male releases. This requires careful weighing of the 
risks and benefits in each situation. Insecticide resistance should be carefully monitored, 
not only in the pre-suppression phase, but in the broad context of any IVM strategy [61]. 
Long-term use of adulticides should be avoided because of stakeholder perception and 
the risks of resistance and potential impact on non-target organisms and the environ-
ment. 
Indoor residual spraying using pyrethroid or other insecticide classes can reduce the 
presence of Ae. aegypti females because these prefer biting and resting indoors. This is 
showing promising results in tropical and subtropical areas of Latin America [69]. 
3. Selecting Pilot Trial Field Sites  
Well-designed studies demonstrating the local public health value of any unfamiliar 
vector control approaches are critical [46]. Iyaloo et al. [70] review the criteria for SIT ideal 
pilot site selection (Table 3), although finding sites that fulfil all criteria satisfactorily and 
that show initial similar densities of mosquito in intervention and non-treated areas is rare 
and there is likely to be some compromise. 
Some initial and/or historical vector knowledge at candidate sites is essential. The 
site selection process should be collaborative and include the local and regional mosquito 
control services, SIT experts with experience in other locations, those who are planning 
production, vector biologists, and local authorities. This will help identify sites that offer 
a high probability of a convincing demonstration of mosquito population reduction.  
Table 3. Important criteria for selecting pilot study sites. 
Entomological: Initial or historical estimates of vector bio-ecology and density, 
validation of monitoring tools (traps adapted to the context).  
Ecological: The degree of ecological isolation. 
Logistic: The expected sterile male mosquito production levels that would be required 
for the site, the constraints (geographical, topographical, etc.) related to mass releases.  
Social/ Financial: The expected political/social stakeholder support available locally 
and regionally. 
The pilot study should be considered as a possible starting point for an operational 
project, therefore, when possible, the pilot sites should be located in an area from which 
the release progression can be extended as in a rolling-carpet principle [4,15]. 
3.1. Site Size 
Insects 2021, 12, 191 10 of 26 
 
 
The size for the pilot target area must provide an opportunity to successfully quantify 
the impacts of SIT [71]. Although there is no formula for calculating an adequate study 
size, extremely small sites (<3 ha) will not be convincing and excessively large sites (>20 
ha) can be unnecessarily costly or time-consuming and can reduce the likelihood of 
success due to production and monitoring challenges. In general, the minimum area of 
the study sites should have a radius similar to the average dispersal distance of wild 
adults in that environment, but this may not be initially known. Experience suggests, how-
ever, that for an adequate demonstration of effect, a pilot field-site may be as small as 3–
10 hectares. 
3.2. Replication—How Many Sites? 
The number and size of pilot areas will pragmatically depend on practical constraints 
such as suitable site availability, staff, and financial capacity (for detailed guidance in 
study design see [72]). Resources for surveillance, community engagement, and 
production are always limited and may be stretched in preparing for just two of the 
smallest sites available; this is a common starting point for nascent programs and most 
initial trials have no replication. The reference site(s) mosquito control activities will be 
managed according to the usual local vector control strategy and the test site(s) will 
receive sterile male releases as part of a more comprehensive IVM strategy [26].  
The primary aims of the trial are to demonstrate that SIT can work in this location 
and that local operational capacity can be developed. Even with a single pair of reference-
test sites, a random selection between these sites for sterile release allocation is advised. 
Where more than a single pair is available, contemporary data from two, or more, 
reference areas helps obtain a more robust comparison. Where there is sufficient time, 
reference and treatment sites can be alternated after two, or more, years. Because of 
inherent variability in mosquito population size due to temporal (seasonal) fluctuations 
and spatial heterogeneity due to landscape and host (human) characteristics, single-site 
studies without a contemporaneous comparison reference area (i.e., pre-post designs) 
provide lower-quality evidence. There may be longitudinal or spatial trends or other 
population-level changes not attributable to the intervention which can produce errors of 
interpretation. 
More randomized, replicate sites reduce the risks of confounding and bias, and give 
improved estimates of differences in outcome between treated and non-treated areas (e.g., 
type of urbanization, socio-economic variables, human behaviour). This may be 
demanding for pilot trials as it requires more suitable sites that can be sufficiently isolated 
(minimizing mosquito migration), and sufficient resources to conduct monitoring 
activites and sterile insect production. Replicated studies are, however, the only means to 
demonstrate effect sizes in a statiscally convincing way. 
3.3. Site Isolation 
Among the most important criteria for an SIT test site is the level of isolation, be it 
ecological or artificially achieved, and a first screening for suitable sites can use satellite 
maps. The movement of adult mosquitoes from surrounding areas can confound data 
interpretation and prevent a solid, evidence-based trial outcome. This contamination can 
be caused both by immigration of fertile wild female mosquitoes to the test site from 
surrounding areas, and migration of sterile males out of the release area and into the 
reference site(s).  
When trials take place in a village or semi-rural setting, an uninhabited or 
ecologically inhospitable surrounding landscape may provide a natural barrier to 
migration for Aedes spp. If test and reference areas are within the same urban setting, 
however, they may need artificial isolation. There are a number of methods for reducing 
between-site contamination. One option is to ensure that clusters are separated by a 
sufficient buffer zone of approximately 2× mosquito dispersal distance estimates; several 
studies usefully estimate the flight distance of Ae. aegypti and Ae. albopictus females [73–
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78], although this varies according to landscape, natural resources, larval site distribution, 
climate, etc. [79]. Another option is to use a ‘fried egg’ design [4,15]; in this, continued 
releases of sterile males into buffer zones will protect the test area from invasion by fertile 
females. The buffer zones, although treated, are not included in the population monitoring 
and only serve as protection for the test area. This can be demanding for mosquito 
production. A further option is to install dense barriers of lethal traps or ovitraps, but the 
width and actual efficacy of such barriers must be determined in context [80]. In extreme 
cases, barrier zones have been produced by a combination of predatory fish, intensive 
source reduction, and adulticiding [81]. 
3.4. Presence of Vector-Borne Disease 
Working in a area where endemic mosquito-borne diseases are common may pose 
ethical and communication challenges. Disease cases in the pilot area, which may have 
been imported through human movement, could affect perception of the success of the 
strategy and, in an epidemic situation, substantial adulticide treatment could be required. 
Passive transportation of mosquitoes (e.g., by cars) can be important dispersal routes for 
Aedes species [82] and could contribute to maintained pathogen transmission. It may be 
possible to select an area free of disease transmission, although, pilot sites should also 
represent the regional environment to which SIT would be operationally deployed. Where 
there is local transmission, stakeholder messaging must be careful not to create an 
expectation of epidemiological outcome from the trial and emphasise that current vector 
control should continue during the trial period.  
4. Characterizing Study Sites 
Once the candidate sites have been identified, there is a period of characterization 
before a trial can begin (Figure 1). This consists of two parts, the human component, and 
the entomological component, and unless the area is unusually well-studied and baseline 
entomological data exist already, this will take at least a year. 
4.1. The Human Component: Community Engagement 
Locally relevant authorities should be contacted for their approval and careful 
engagement with the community should begin to present the plans, hear and understand 
their concerns, and ensure that expectations for the project are clearly communicated [83] 
(Figure 2). This will include a detailed local plan for integrated Aedes management 
(including larval habitat reduction), surveillance (ongoing mosquito abundance 
monitoring), anticipation of between-sector collaborations and supporting activities 
together with social engagement and ancillary aspects of vector control [48]. The 
stakeholder/community engagement plan will initially be similar between sites, though 
once these are confirmed as suitable and the randomization of treatment has happened, 
the communication will need to be shaped slightly differently in the test and reference 
sites. 
When first communicating about a specific trial, a perception study of various 
segments of the populace will help to understand how the information is being received 
and will record possible questions, concerns, expectations, and misconceptions. This 
characterization of local people can help shape key messages addressed to those with 
reservations. Translating the technical concepts in a way that can be understood by lay 
people, however, is not trivial and is culture-dependent [12,48]. Willingness to be 
involved may vary according to the cultural and social context; this type of survey helps 
to plan the level, frequency, type of information, and method of information transfer, 
required. For any vector control intervention, a community or public acceptance plan aims 
to achieve an informed and accepting population at the field sites [30].  
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Information and Acceptance at Local Scale 
The term ‘informed’ means that the people living at the field sites, and often the 
neighboring population, have been provided with information about the trial in a locally 
appropriate and accessible way. This can entail the development of locally-specific 
glossaries and engagement practices that ensure concepts are understood and sufficient 
inclusion is achieved [84,85]. For SIT against mosquitoes, the information should include: 
the basics of target mosquito species biology and ecology; the role of this species in 
nuisance and in disease transmission; challenges of mosquito control in urban areas; what 
is SIT; what is the plan of activities for the pilot study; what are the short- and long-term 
expectations of the trial; who is funding the project and who are the collaborators [29]. 
The Life CONOPS website [86], which provides information about a recent field trial in 
Greece, gives excellent examples of this. 
Acceptance is a key concept in a pilot study and an informed population can give 
acceptance via the agreement of their elected or designated representatives. Consent is 
different and can only be given by individuals for a specific item or topic [87]. In this 
context, consent may be required for placing monitoring equipment in, or adjacent to, 
people’s homes or for gaining access to property in order to reduce mosquito larval 
development sites (source reduction) on private property (door-to-door campaigns).  
4.2. The Mosquito Component: Entomological Characterization 
The local mosquito population must also be well-understood to guide trial design 
and this understanding is based on occurrence, abundance, and spatial and temporal 
distribution data. Preliminary sampling at periods of known high density can help with 
initial site choice, but an annual cycle, ideally more, of baseline entomological data for 
potential sites will confirm final selection (Figure 1). These data will provide detailed 
information on: (i) the level of isolation, (ii) the density of adult mosquitoes, (iii) seasonal 
variation, and (iv) the similarity between the sites that could serve as test and reference 
zones. With sufficient data from a test and reference site, the comparison can be made 
both within (pre-release year vs. post-release year) and between (test vs. reference) sites.  
4.2.1. Baseline Entomological Data Collection 
For SIT, the entomological data must be able to evaluate the fluctuations of adult 
mosquito densities, and once releases have started, the ratios of sterile to wild males, and 
natural variation in fecundity and fertility. Here, we focus on planning and testing SIT 
against a single species, whereas a challenge for many tropical countries are co-occurring 
disease-transmitting mosquitoes. Sympatric occurrence of more than one Aedes mosquito 
species (e.g., Ae. albopictus and Ae. aegypti) adds complexity to trial design and raises 
questions about ecological effects on non-target mosquito species; not all situations with 
several vector species are suitable for SIT. In these situations, any pilot trial will need to 
anticipate changes in the ecology, species composition, and relative densities in response 
to change in density of the target species (Figure 1). No current mosquito SIT program 
aims to control multiple sympatric vector species, although this is now being done for 
some agricultural pests [88]. 
Sites must be characterized using several trapping methods to minimize any bias 
associated with a specific method. Vector control teams usually conduct Aedes surveys in 
urban neighbourhoods using standard methods to evaluate the conventional indices: 
House, Breteau, and Container Indices. These surveys provide information on the 
presence/absence of aquatic stages (larvae and pupae), their spatial distribution within 
the area, and the typology of potential breeding sites, and makes it possible to estimate 
population densities indirectly. 
Trap location affects attraction and therefore the data collected. These must be 
selected similarly across sites to avoid introducing sampling bias. To optimize efforts and 
to ensure that population estimates are reliable, trap location should be refined during 
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baseline monitoring. Statistical analysis of subsamples can determine the catch-reduction 
effect of increasing trap density or help to eliminate trap sites that consistently capture no 
mosquitoes [62,89]. 
4.2.2. Trapping Devices for Population Monitoring 
In general, sampling methods should be practical and standard. When only one 
species of Aedes is present, ovitraps are the simplest and cheapest method, and can be 
complemented by fortnightly or monthly adult collections. When more than one species 
of Aedes coexists in the same area, then species identification of the collected eggs or 
resulting larvae is essential. In this situation, the entomological data collection should fo-
cus on regular (weekly) adult trapping, which allows rapid species identification. Less-
frequent (two-weekly or monthly) ovitrapping can then be used, and a subsample sent for 
fertility assessment and species identification. Fertility data are used to assess SIT 
efficiency during the release period and baseline field fertility data allow technical practice 
and protocol validation.  
For Ae. albopictus, ovitraps should be placed in gardens, in shade or low vegetation, 
and preferably sheltered from wind and sun, most frequently around homes. Aedes aegypti 
trapping is also usually done inside houses; the ease of access and disturbance to residents 
must be considered and sites close to houses can be preferable. To lower the risk of 
interference, these are best-placed avoiding premises to which adulticide treatments are 
applied. 
Adult mosquito densities can be assessed using various traps; BG Sentinel® odor-
baited traps [90] are widely used for sampling Aedes globally. However, these require a 
power source and may not be suitable for all contexts; other trapping systems such as 
Adultrap [91] or sticky traps [92] can be alternatives. Except for male-only mark-release-
recapture experiments [77], the baseline entomological data collection assumes standard, 
or locally determined, sex ratios; therefore a sex bias in trap attraction is a lesser issue.  
Trap density will depend on the study site area, but a minimum of 30 active traps 
(i.e., attracting mosquitoes during the preliminary survey) per site is needed to collect 
sufficient data. For large sites (>20 ha), cluster monitoring can be used; clusters of traps 
within randomly chosen blocks allow estimates per block and comparison between blocks 
within a study area (i.e., periphery vs. center).  
4.2.3. Density and Dispersal Estimation: Mark Release Recapture Studies 
Baseline sampling should be combined with mark–release–recapture (MRR) studies 
performed three or four times a year at expected highs and lows of mosquito abundance. 
These studies estimate adult population size by releasing marked mosquitoes followed by 
collections that include both those released and the wild population [77,93,94]. The ratio 
of released adults to total adults collected in traps allows estimates of absolute population 
size. Dispersal distance can be estimated from the distances travelled by marked 
mosquitoes from the release point. With these studies, the ethics and safety of releasing 
non-sterile adults in an urban environment must be considered; releasing females is 
widely thought to be undesirable [95]. 
Contemporaneous comparisons of the MRR population estimates and population in-
dices from ovitrapping and adult trapping will allow future use of index data to estimate 
absolute population sizes [93,96]. Additionally, MRR can be used to evaluate site isolation 
and at later stages the mortality and competitiveness of the sterile males [97].  
The reliability of MRR-derived estimates depends on the intensity of collection ef-
forts. These vital studies must be effectively planned to have sufficient numbers of male 
mosquitoes to release (>5000 males per release station), and to have sufficient traps and 
human resources to perform the collections. Practice with MRR helps to train staff, assess 
requirements, and refine the local MRR design, and will be helped by the established 
monitoring network of adult traps. Alternative adult collections for MRR can use human 
landing catches [98], although these target female mosquitoes and are not recommended 
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in areas where disease transmission is known to occur. Other methods such as back-pack 
aspiration of eaves and other resting habitats or ‘mosquibat’ sweeping sticky rackets may 
also be used [96]. The advantage of these methods is their mobility, which can allow 
coverage of larger areas and a focus on sites where mosquitoes are usually found (near 
tree trunks, in shaded areas, under vegetation, near fruit for feeding); they require 
standardized protocols to reduce sampling biases from operators.  
5. Mosquito Sourcing: Purchase or Production? 
The number of sterile males required for release can be substantial and two options 
exist: local production and purchase/importation. If local infrastructure (insectary and 
irradiation source) is unavailable or too expensive, acquiring sterilized mosquitoes from 
an established facility, sometimes abroad, is possible. Each route has both advantages and 
disadvantages (Table 4) and the United Nations’ Food and Agriculture Organisation 
(FAO) or the IAEA can serve to introduce interested parties to established production 
facilities. It may be recommended or required to use a local mosquito strain for a pilot 
trial, though this might not be applicable to an operational area-wide phase, or to 
countries relying on another country’s production capacity.  
Table 4. Advantages and disadvantages of local production and importation of sterile males for 
sustaining a sterile insect technique (SIT) pilot trial for vector mosquito management. 










 Ease of logistics 
 More control/freedom 
over rearing schedule 
 Builds local capacity 
 Better quality control 
 No need for substantial initial 
investment 
 No need for irradiation source 












  Initial investment for a 
sufficiently large 
insectary 
 Irradiation source must 
be available and 
convenient 
 Staff training costs 
 Possible loss of quality and 
competitiveness following long 
distance transportation  
 Use of a local strain may not be 
possible (if the provider can not rear 
different strains) 
 Importation permits required 
 Logistic chain management 
 Risk of gene flow to wild population 
if sub-sterile males from a non-local 
strain are released 
5.1. Local Sterile Male Production 
One of the major challenges at SIT pilot scale is the ability to establish a reliable and 
efficient mass-rearing system that can produce a sufficient number of sterile males to 
impact the target population. Mass rearing is not a trivial undertaking and any SIT 
program using local production must solve ‘input questions’ such as how to rear larvae 
and adults at high densities or how to optimise egg production from adults. Output 
measures to consider are not only the quantity but also the quality of the mass-produced 
sterile males [99]. Routine quality estimation using proxy measures, such as pupal size, 
adult survival, flight ability and mating capacity, must take place regularly. 
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5.1.1. Rearing Facility 
Rearing facilities must continuously provide sterile males for the duration of the re-
lease phase. It is also important to consider the scale up of mosquito production to the 
level of anticipated future release numbers (from pilot study to field implementation) at 
the design stage, including the possibility of a modular, expandable facility. There is an 
initial learning curve and mosquito production will increase with rearing experience, 
mechanization and sexing efficiency. The construction and operation of mass-rearing fa-
cilities for SIT may represent a major investment and requires strong technical, political, 
and financial support for success. Detailed guidance for a mass-rearing facility with a 
worksheet for scoring pertinent factors is available [43].  
5.1.2. Mass Rearing Process 
Significant advances have been made in mass-rearing technology, formulation of 
mosquito diets, and sterilization using precise and uniform irradiation dosage. Prototypes 
of mass-rearing equipment (racks, breeding trays, mass rearing cages) have been 
developed and tested. The standard operating procedures (SOPs) for routine rearing and 
quality control produced by the FAO/IAEA can be easily adapted [16] and the mass-
rearing systems available are easy to use and can produce up to 900,000 pupae per 
rack/week for Aedes species [100,101].  
5.1.3. Sex-Separation Systems 
One criticial step for mosquito SIT is an efficient sex-separation method, because the 
release of females has to be avoided. Currently for Aedes spp., which are sexually 
dimorphic, this mostly relies on mechanical separation techniques, which can lead to 99% 
male purity [102] but are highly operator-dependent. The development of a genetic sexing 
system (GSS), e.g., the separation or killing of females enabling the production of a male-
only population [103,104], or other innovative methods to improve sexing accuracy would 
be a valuable asset to the Aedes spp. SIT package [105]. An automatic sex-sorter developed 
by Wolbaki is being tested at the Insect Pest Control Laboratory (IPCL) of the IAEA, and 
estimates a female contamination of <0.3% at a rate of up to 150,000 pupae/hour [106]. 
5.1.4. Sterilization  
Sterilization is performed during the last developmental phase, at the earliest on 
pupae aged >24 h, when the organism is less affected by the radiation (i.e., when most of 
its somatic cells have completed their development and only the reproductive cells are 
altered) [107]. However, variation in growth rate and in the optimal window for pupae 
collection inherent to a larger-scale rearing process can lead to a significant loss of males. 
The sterilization of males as adults is more efficient in terms of yield and labour for small-
medium sized programs. 
The doses necessary for complete or partial sterilization of male mosquitoes must be 
established for the release strain using the irradiation source available for the pilot study. 
The dose required depends not only on the Aedes species but also on several technical 
parameters including the radiation source, dose-rate, and container [108]. The 
effectiveness of SIT depends on both the competitiveness and sterility of the released 
males. High radiation dose and handling practices are associated with reduced vitality of 
males resulting in lowered mating competitiveness; the right dose is that which maintains 
both competitiveness and efficiency [109–111]. 
5.2. Quality Control 
Whichever path is taken to source the sterile males, quality control is essential. Many 
aspects of production can affect the quality of the males: diet quality and quantity, 
artificial environment conditions, genetic drift, rearing densities, handling during 
separation, transport, and sterilization. Important data on the mating competitiveness, 
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flight ability, survival, and dispersal of the sterile males used should be gathered during 
the preparatory phases (Figures 1 and 2). Detailed information on these various 
procedures is found in the IAEA/WHO guidance document [17]. 
Some technical standards, such as the level of residual fertility allowed and the 
resulting potential risk of introducing undesirable alleles (such as insecticide resistance) 
to local populations, or the percentage of female contamination allowed in the male 
releases and their vector competence risks, may be pertinent. Estimation of these should 
be discussed with the relevant authorities and scientific experts.  
6. Trial Implementation 
6.1. Enhanced Stakeholder Engagement 
Initiating the trial phase requires maintaining active support and participation of 
multiple stakeholders because, even if the trial is local, awareness will be area-wide 
(Figure 2). This also anticipates future application in wider and different habitats and for 
different purposes, including disease prevention and community well-being. Enhanced 
stakeholder engagement at the trial sites increases effectiveness and information should 
be delivered through many means. Prior engagement has set the scene and it is now the 
time for reinforcing an accurate description of the release and monitoring activities and 
their objectives. This can be done through town hall meetings, delivery of leaflets, and 
face-to-face methods, depending on the size of the sites. 
Although sterile male releases will be performed by project staff, source reduction, 
larvicide application, and the use of adult traps may involve local vector control services 
and/or private control companies. The participation of local residents helps to reduce 
background mosquito populations, but can be hard to motivate especially if mosquito 
numbers fall. Participation of the vector control services in source reduction on private 
property can be an incentive to stimulate public participation, a route for engagement or 
act as enforcement through regular inspection [53]. In some situations, however, it may 
be viewed as a sufficient intervention by local residents, reducing their own responsibility 
[112,113]. Maintaining an open and communicative relationship with all stakeholders 
helps to foster participation and supports the delivery and sustainability of the pilot 
deployment.  
6.2. Optimizing the Release Strategy to Meet Objectives 
In any SIT pilot trial it is essential to define the aim of the interventions (reviewed in 
[4]) and to estimate the magnitude of the effect and predict the likelihood of success. These 
enable calibration of sterile male production and design of the release strategy, and allow 
for effective evaluation. Although SIT can be also applied to prevent the invasion and 
establishment of an invasive population into a new area or to contain its introduction, the 
suppression goal for an established population is most often to maintain this below a 
specified threshold. This then reduces the biting nuisance to an acceptable level, and may 
ultimately suppress disease transmission. In certain contexts, local eradication of a 
population could be the aim; this may apply more easily to recently invaded areas or 
island settings where initial mosquito densities and immigration are low. 
Predictive mathematical models help define an achievable suppression level and 
design the size and types of releases (continuous, periodic, or pulse) [114,115]. They will 
be based on parameter estimates from baseline entomological field data (density, site size, 
and isolation level), the performance characteristics of the sterile males (level of sterility, 
competitiveness, survival, and dispersal capacity), and the production capacity.  
6.2.1. When to Start? 
Releases of sterile males have the strongest suppression effect when the numbers of 
released males overwhelm the wild male population, so releases should start when the 
target species density reaches a seasonal minimum or when mosquitoes have been 
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temporarily reduced by a pre-release suppression phase [116]. In some regions, Aedes 
mosquitoes show a marked seasonal fluctuation in population density [117], more clearly 
so in temperate areas [89,118–120].  
6.2.2. Release Ratios 
The sterile-to-wild male release ratio in sterile insect programs against agricultural 
pests can vary from 7:1 (for some tse-tse fly sub-species) to 100:1 (in some contexts for 
screwworm) [121]. The appropriate release ratio depends on several factors, including the 
spatial distribution of the wild population, the sterile male dispersal, survival, and mating 
competitivity. For mosquito SIT trials, a release ratio of 10:1 is generally the minimum 
necessary to maintain a high likelihood of wild females mating with a sterile male. This 
‘guidance’ ratio can be adjusted by ongoing monitoring of local densities and as the 
release intervention progresses. With constant release effort, this ratio will increase over 
time if the SIT is efficient in reducing the wild population. 
6.2.3. Release Frequency 
The optimal release frequency aims to maintain at least a minimum of the desired 
sterile to wild male ratio during the release period. Understanding the daily mortality of 
released males is thus important and will come from the early MRR studies. In agriculture, 
releases are generally performed weekly or biweekly. A recent mosquito SIT (combined 
with IIT) in China [11] used a release ratio of 5:1 three times per week. Practicalities will 
also influence this decision and it may not always be cost-effective to release sterile males 
continuously/daily; instead teams can use less frequent but more intense pulses [114]. 
6.2.4. Release Locations 
The spatial distribution of ground-level release stations is informed by the mean 
dispersal distance of male mosquitoes estimated by the earlier MRR studies and by the 
patterns of relative density established through baseline monitoring. Male Ae. albopictus 
typically travel 100–150 m [77,93,122], but have been found 1–2 km from their release point 
[122]. There are sex differences in dispersal in some environments, with most females 
found within 250 m of their release [122]. Both sexes of Ae. aegypti typically disperse less 
than this and most estimates suggest 150–250 m is typical [123–126].  
Early trials released male pupae [49], although more recently young adults have been 
used [11] because remaining in the insectary with access to food for a few days improves 
competitiveness and survival [127,128]. More dispersed, aerial releases of adults using 
drones can provide effective and even coverage of larger areas [129].  
6.2.5. Marking Mosquitoes 
Most agricultural pest control programs release color-marked insects to distinguish 
sterile males during field monitoring and in MRRs [130]. This is not ideal for mosquitoes 
because the fluorescent color might create anxiety in people. The dust may also alter 
behavior and is lost with time, making it difficult to estimate the competiveness of the 
released males. The use of internal marking also detectable in the semen (e.g., rhodamine 
[131,132], or a stable isotope [133]), may become alternatives and allow both identification 
of released males and their contribution to the insemination of wild females. Other 
innovative methods, including liquid-applied fluorescense and synthetic DNA-tags, hold 
great promise for future studies [134]. 
6.3. Pilot Trial Duration 
Aedes albopictus populations present a particular challenge as the immediate effect of 
SIT can be buffered by their ability to diapause. They can produce quiescent embryos that 
may hatch weeks or months after oviposition. These embryos are insensitive to SIT and 
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releases may need to be performed for at least two seasons to be able to clearly identify 
effects.  
Achieving the necessary production and refining release logistics are likely to take 
several months and the full potential of pilot trials may not be realized in the first season. 
In some situations, such as where the site is well isolated and has initial low-density levels 
of mosquito population, a single season may be able to achieve identifiable reductions. 
Suppression obtained during the first year will led to increased effectiveness 
subsequently, therefore a pilot program of 2–3 years or seasons is desirable. 
7. Pilot Trial Evaluation 
7.1. Defining Success 
In most cases, the ultimate objective of using SIT against Aedes is to maintain low 
mosquito population density in a sustainable way and, where relevant, to reduce or 
prevent arbovirus transmission. Where disease transmission is not an issue, the reduction 
target may be to a density that is socially acceptable (e.g., in touristic areas). During a pilot 
trial, however, the objective is to demonstrate if, and how, a reduction of the target 
population is possible. It will be difficult in an SIT pilot trial against Aedes to demonstrate 
an impact on Aedes-borne disease transmission. People move around widely and the 
likelihood of being bitten by infected mosquitoes outside the test area remains the same, 
irrespective of vector suppression at the test site. This is a question of scale. Because pilot 
tests are carried out on a relatively small scale, only entomological indicators are appro-
priate to evaluate the outcomes. 
Later stages may move to larger scale trials, and these can evaluate the effect of SIT 
intervention on reducing the diseases transmitted by Aedes spp. mosquitoes (e.g., a sero-
prevalence survey in communities with and without SIT) using guidance published by 
WHO and IAEA [17]. Island settings where human populations move little and where the 
entire island could be covered by release of sterile mosquitoes might provide a situation 
and an opportunity to reliably estimate the impact of SIT on epidemiological outcomes. 
7.2. Evaluation of Field Release Efficacy 
Suppression in population size is usually measured through a sufficient reduction in 
population size relative to pre-release and/or comparison site densities. Comparability is 
improved if the natural temporal and spatial variation is controlled for through 
replication, longer studies, or site-switching (see Section 3.2). Statistical models informed 
by baseline site characterization data can help to predict the reduction in population size 
likely to be detectable using the data that are routinely collected (via power analysis). For 
all measures, geographic information systems (GIS) and accessible spatial data are 
increasingly being used in vector management programmes to support field population 
evaluation [135]. 
The impact of sterile male releases can also be assessed by measuring the proportion 
of egg sterility in eggs from ovitraps. A net induced egg sterility of 80%, achievable with 
sufficiently high release ratios, may be a good target to deliver a clearly observable reduc-
tion in the adult population. Further comparison of wild male/female captures between 
the release and control areas will give date-specific estimates of population reduction ex-
pressed as 100% × (1 – wild mosquitoes per trap per day in treated site/wild mosquitoes 
per trap per day in non-treated site).  
When mosquito densities are low, conventional entomological indicators may not be 
suitable for evaluating efficacy due to large variation in trap catches. In these cases, nui-
sance and biting rates may be useful indicators. Salivary antibody-based biomarkers can 
also be used as secondary indicators of a reduction in biting [136]. 
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7.3. Capacity Development 
Another objective, sometimes lost from view, is that of capacity development. Staff 
in all trial components from stakeholder engagement and insectary management through 
to field monitoring all develop their skills and contribute this capacity to future vector 
control initiatives. This has great value, particularly when the initial experience of the 
teams is limited. The success of many SIT programs depends on overcoming 
unanticipated challenges, such as lower/higher than expected mosquito populations, high 
levels of immigration or mating failure, and inefficient initial reduction of the wild 
population. The ability to produce and release a high quality sterile mosquito does not 
mean that the programme will be successful. The quality of the technical aspects and the 
quality of the implementation strategy are equally important, and both will improve with 
staff experience, and time (Figure 2). 
7.4. Evaluation of Production and Release Quality Control 
The competitiveness of a sterile male is the likelihood of a wild female mating with a 
sterile male when sterile and wild males are present in equal numbers, and continuing 
efforts must be made to improve the competitive quality of sterilized males produced in 
any mass-rearing system. During a trial, indirect measures of sterile male competitiveness 
can be made through MRR experiments using marked sterile males, and relating the 
sterile-to-wild male ratio to the observed egg sterility level in the field. This type of 
evaluation should be conducted regularly and especially after any change in mass rearing 
procedures, transport, or release procedures. Results will help to identify issues and 
permit adjustment of the release strategy in the field. 
7.5. Feedback to Stakeholders 
An important element of stakeholder relations is providing feedback on the progress 
and results of the trial (Figure 1). Local feedback at trial sites can be delivered informally 
and form part of regular data collection. If nuisance and biting rates have been recorded, 
then these provide immediate local feedback and could also be established as a metric. 
Health authorities and strategic stakeholders, need accurate, precise, and clearly pre-
sented analysis and evaluation.  
Proceeding with SIT depends in part on having the political and financial support 
needed to sustain the program until demonstrable reductions are achieved. One aim is 
often to produce preliminary data that informs future production and release capacity, 
and it is essential that this measure of success is also understood by relevant stakeholders. 
With appropriate expectations, local experience will grow and it is highly likely that the 
releases will be ‘successful’.  
8. Conclusion and Perspectives  
This review presented a practical and accessible introduction to using SIT against 
Aedes mosquitoes and, although an Aedes SIT package is now close to being ‘field-ready’, 
many steps and parameters within it will continue to need local adjustment and 
validation. For those who decide to progresss further down this path the Insect Pest Con-
trol Section | Joint FAO/IAEA Programme of Nuclear Techniques in Food and Agriculture 
has now published several detailed guidance documents addressing this process [137]. 
The integration of SIT into vector control practices should be guided by sound science 
based on a harmonized and structured process for data collection, interpretation, and re-
porting. In parallel to pilot testing, further important research must continue to improve 
future implementation. 
The development of SIT for agricultural pests took decades before reaching a level of 
delivery and know-how that was efficient and cost-effective as part of area-wide inte-
grated pest management approaches and the same will be true for SIT against Aedes mos-
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quitoes. The aims of this review were to provide an overview and to support teams ex-
ploring the possibility of pilot field trials. Failure can be costly, and failure due to poor 
preparation and excessive haste might have long-term negative impacts. Here we hope to 
improve the chances of SIT success by providing a clear initial route map, and interested 
parties will build on this with collaborations and seek further guidance [138]. 
The outcome of a pilot trial can determine whether an approach integrating SIT will 
be granted local and regional public acceptance, and can raise the interest of decision-
makers for future operational use. It is encouraging to see international organizations such 
as the WHO take a position acknowledging the role of SIT as a promising technology to 
be deployed against vector-borne diseases. Influential international institutions will also 
be pivotal in providing future guidance for critical components of the SIT research process 
and potential follow-up positioning on key issues, such as recommendations and policy 
advice, to support a more flexible regulation of SIT as part of the IVM approach for vector-
borne disease prevention.  
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